Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lancaster

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
BMC Infectious Diseases|August 13, 2015
Supporting Option B+ scale up and strengthening the prevention of mother-to-child transmission cascade in central Malawi: results from a serial cross-sectional studyMichael E Herce, Tiwonge Mtande, Frank Chimbwandira, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteresDavid E Uehling, Kelly H Donaldson, David N Deaton, et al.
BMJ Open|June 15, 2022
Peer-based Retention Of people who Use Drugs in Rural Research (PROUD-R<sup>2</sup>): a multisite, randomised, 12-month trial to compare efficacy of standard versus peer-based approaches to retain rural people who use drugs in researchApril M Young, Kathryn E Lancaster, Sarann Bielavitz, et al.
Harm Reduction Journal|May 2, 2026
Transitions from first drug use to illicit opioid and injection drug use in a multisite rural U.S. cohort of people who use drugsRob J Fredericksen, Adams Sibley, Kathryn E Lancaster, et al.
The International Journal on Drug Policy|October 8, 2023
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communitiesAngela T Estadt, William C Miller, David Kline, et al.
Journal of Medicinal Chemistry|April 28, 2006
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonistsDavid E Uehling, Barry G Shearer, Kelly H Donaldson, et al.
Journal of the International AIDS Society|November 21, 2022
Hazardous alcohol use and HIV indicators in six African countries: results from the Population-based HIV Impact Assessments, 2015-2017Gregory C Chang, Christine A West, Evelyn Kim, et al.
Implementation Science : IS|August 11, 2020
Comparing a standard and tailored approach to scaling up an evidence-based intervention for antiretroviral therapy for people who inject drugs in Vietnam: study protocol for a cluster randomized hybrid type III trialMinh X B Nguyen, Anh V Chu, Byron J Powell, et al.
The International Journal on Drug Policy|January 16, 2024
Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortiumKathryn E Lancaster, Melissa Stockton, Molly Remch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2024
Updated Risk Score Algorithms for Acute HIV Infection Detection at a Sexually Transmitted Infections Clinic in Lilongwe, MalawiGriffin J Bell, Jane S Chen, Courtney N Maierhofer, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
BMC Infectious Diseases|August 13, 2015
Supporting Option B+ scale up and strengthening the prevention of mother-to-child transmission cascade in central Malawi: results from a serial cross-sectional studyMichael E Herce, Tiwonge Mtande, Frank Chimbwandira, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteresDavid E Uehling, Kelly H Donaldson, David N Deaton, et al.
BMJ Open|June 15, 2022
Peer-based Retention Of people who Use Drugs in Rural Research (PROUD-R<sup>2</sup>): a multisite, randomised, 12-month trial to compare efficacy of standard versus peer-based approaches to retain rural people who use drugs in researchApril M Young, Kathryn E Lancaster, Sarann Bielavitz, et al.
Harm Reduction Journal|May 2, 2026
Transitions from first drug use to illicit opioid and injection drug use in a multisite rural U.S. cohort of people who use drugsRob J Fredericksen, Adams Sibley, Kathryn E Lancaster, et al.
The International Journal on Drug Policy|October 8, 2023
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communitiesAngela T Estadt, William C Miller, David Kline, et al.
Journal of Medicinal Chemistry|April 28, 2006
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonistsDavid E Uehling, Barry G Shearer, Kelly H Donaldson, et al.
Journal of the International AIDS Society|November 21, 2022
Hazardous alcohol use and HIV indicators in six African countries: results from the Population-based HIV Impact Assessments, 2015-2017Gregory C Chang, Christine A West, Evelyn Kim, et al.
Implementation Science : IS|August 11, 2020
Comparing a standard and tailored approach to scaling up an evidence-based intervention for antiretroviral therapy for people who inject drugs in Vietnam: study protocol for a cluster randomized hybrid type III trialMinh X B Nguyen, Anh V Chu, Byron J Powell, et al.
The International Journal on Drug Policy|January 16, 2024
Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortiumKathryn E Lancaster, Melissa Stockton, Molly Remch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2024
Updated Risk Score Algorithms for Acute HIV Infection Detection at a Sexually Transmitted Infections Clinic in Lilongwe, MalawiGriffin J Bell, Jane S Chen, Courtney N Maierhofer, et al.
Pageof 25